eISSN: 2081-2841
ISSN: 1689-832X
Journal of Contemporary Brachytherapy
Current Issue Archive Supplements Articles in Press Journal Information Aims and Scope Editorial Office Editorial Board Register as Author Register as Reviewer Instructions for Authors Abstracting and indexing Subscription Advertising Information Links
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank

1/2011
vol. 3
 
Share:
Share:
abstract:

Clinical Investigations
Adjuvant high dose rate brachytherapy for soft tissue sarcomas: initial experience report

Julie A. Bradley
,
Sara H Kleinman
,
Jason Rownd
,
David King
,
Donald Hackbarth
,
Robert Whitfield
,
Dian Wang

J Contemp Brachyther 2011; 3, 1: 3-10
Online publish date: 2011/03/31
View full text Get citation
 
Purpose: Adjuvant high-dose-rate brachytherapy (HDRBT) offers advantages over low dose rate brachytherapy (LDRBT), although there are little data on local tumor control and treatment related toxicity. We report outcome in patients with primary, recurrent, and metastatic extremity and superficial trunk soft tissue sarcoma.

Material and methods: Eleven patients (12 sites) with intermediate or high grade sarcoma were treated with adjuvant HDRBT following surgical resection. Patients were treated at 3.4 Gy fractions delivered twice daily to a total dose of 34 Gy (1 patient received 9 fractions).

Results: With median follow-up of 20.8 months, 1 patient developed a local recurrence. 2-year local control and overall survival are 89% and 71%, respectively. Wound complications occurred in 3 sites. Two of the wound complications developed in the area of previous external beam radiotherapy (EBRT).

Conclusion: Surgical resection followed by HDRBT is associated with excellent early local tumor control and acceptable wound complication.
keywords:

sarcoma, brachytherapy, high dose rate, radiotherapy

 
Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.